BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:46 PM
 | 
Apr 01, 2010
 |  BC Extra  |  Company News

MDRNA to acquire Cequent

MDRNA Inc. (NASDAQ:MRNA) will acquire fellow RNAi company Cequent Pharmaceuticals Inc. (Cambridge, Mass.) in a stock deal that values Cequent at about $46 million. Cequent shareholders will own 45% of the combined company,...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >